Indeed, clinical trials have investigated the role of ameliorating protein misfolding in ALS patients previously, such as with arimoclomol, a heat shock protein (HSP) co-inducer that we have shown previously through meta-analysis to significantly reduce behavioural outcome measures in animal models (43). The gene discussed is HSP90B2P; the disease is amyotrophic lateral sclerosis.